Morgan Dempsey Capital Management LLC Purchases 1,247 Shares of Kewaunee Scientific Corporation $KEQU

Morgan Dempsey Capital Management LLC increased its stake in shares of Kewaunee Scientific Corporation (NASDAQ:KEQU) by 41.8% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,229 shares of the technology company’s stock after buying an additional 1,247 shares during the period. Morgan Dempsey Capital Management LLC’s holdings in Kewaunee Scientific were worth $247,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in KEQU. Bank of America Corp DE increased its holdings in Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after buying an additional 443 shares during the last quarter. IFP Advisors Inc increased its holdings in Kewaunee Scientific by 61.5% during the first quarter. IFP Advisors Inc now owns 945 shares of the technology company’s stock worth $37,000 after buying an additional 360 shares during the last quarter. American Century Companies Inc. increased its holdings in Kewaunee Scientific by 43.4% during the first quarter. American Century Companies Inc. now owns 49,182 shares of the technology company’s stock worth $1,937,000 after buying an additional 14,889 shares during the last quarter. OMERS ADMINISTRATION Corp purchased a new stake in Kewaunee Scientific during the first quarter worth about $284,000. Finally, Punch & Associates Investment Management Inc. purchased a new stake in Kewaunee Scientific during the first quarter worth about $788,000. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on KEQU shares. Weiss Ratings restated a “hold (c+)” rating on shares of Kewaunee Scientific in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Kewaunee Scientific presently has an average rating of “Hold”.

Insider Activity at Kewaunee Scientific

In related news, CEO Thomas David Hull III sold 1,854 shares of the business’s stock in a transaction that occurred on Monday, September 29th. The shares were sold at an average price of $43.42, for a total transaction of $80,500.68. Following the completion of the transaction, the chief executive officer owned 39,719 shares of the company’s stock, valued at approximately $1,724,598.98. The trade was a 4.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Elizabeth D. Phillips sold 6,880 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $43.20, for a total transaction of $297,216.00. Following the transaction, the vice president directly owned 8,248 shares of the company’s stock, valued at approximately $356,313.60. This represents a 45.48% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 18,880 shares of company stock valued at $865,241. Corporate insiders own 13.30% of the company’s stock.

Kewaunee Scientific Price Performance

KEQU opened at $43.19 on Friday. The company has a market capitalization of $123.96 million, a price-to-earnings ratio of 10.46 and a beta of 0.68. The company has a quick ratio of 1.63, a current ratio of 2.32 and a debt-to-equity ratio of 0.88. The firm has a 50-day moving average price of $49.13 and a 200-day moving average price of $45.26. Kewaunee Scientific Corporation has a twelve month low of $30.33 and a twelve month high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU) last posted its earnings results on Wednesday, September 10th. The technology company reported $1.10 earnings per share for the quarter. The firm had revenue of $71.10 million during the quarter. Kewaunee Scientific had a net margin of 4.68% and a return on equity of 25.65%.

Kewaunee Scientific Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.